SETBP1

Chr 18AD

SET binding protein 1

Primary Disease Associations & Inheritance

Intellectual developmental disorder, autosomal dominant 29MIM #616078
AD
Schinzel-Giedion midface retraction syndromeMIM #269150
AD
UniProtMyelodysplastic syndrome
UniProtLeukemia, acute myelogenous
UniProtLeukemia, chronic myeloid, atypical
UniProtLeukemia, juvenile myelomonocytic
592
ClinVar variants
43
Pathogenic / LP
1.00
pLI score· haploinsufficient
1
Active trials
Clinical SummarySETBP1
🧬
Gene-Disease Validity (ClinGen)
Schinzel-Giedion syndrome · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
43 Pathogenic / Likely Pathogenic· 312 VUS of 592 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.11LOEUF
pLI 1.000
Z-score 5.95
OE 0.02 (0.010.11)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.10Z-score
OE missense 0.90 (0.840.95)
776 obs / 866.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.02 (0.010.11)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.90 (0.840.95)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.07
01.21.6
LoF obs/exp: 1 / 43.3Missense obs/exp: 776 / 866.8Syn Z: -1.06

ClinVar Variant Classifications

592 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic9
VUS312
Likely Benign186
Benign45
Conflicting6
34
Pathogenic
9
Likely Pathogenic
312
VUS
186
Likely Benign
45
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
14
2
18
0
34
Likely Pathogenic
3
1
5
0
9
VUS
2
297
13
0
312
Likely Benign
0
42
15
129
186
Benign
0
27
1
17
45
Conflicting
6
Total1936952146592

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SETBP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

SETBP1-related developmental and expressive language delay

definitive
ADLoss Of FunctionAbsent Gene Product
Dev. Disorders
G2P ↗

SETBP1-related Schinzel-Giedion midface retraction syndrome

definitive
ADGain Of FunctionAltered Gene Product Structure
Dev. Disorders
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Intellectual developmental disorder, autosomal dominant 29

MIM #616078

Molecular basis of disorder known

Autosomal dominant

Schinzel-Giedion midface retraction syndrome

MIM #269150

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — SETBP1
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence